title: Valvular disease in 2011: Breakthrough for intervention?
abstract: In 2011, both the PARTNER-A trial, in high-risk patients with severe aortic stenosis, and EVEREST II, in patients with mitral insufficiency, showed noninferiority of transcatheter interventions compared with surgery for the chosen primary end points. However, both of the trials, and important registry data, identified limitations of transcatheter valve interventions.
authors.affiliation: Division of Cardiovascular Surgery, University of Zurich, Rämistrasse 100, Zurich CH-8091, Switzerland. volkmar.falk@usz.ch
authors.forename: Volkmar
authors.initials: V
authors.lastname: Falk
mesh_terms: D002404:Catheterization / Q000639:trends*; D006349:Heart Valve Diseases / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation / Q000639:trends*; D006801:Humans; D012189:Retrospective Studies; D016896:Treatment Outcome